Neoplasia/BPH

	Factors associated with Gleason score upgrading in biopsy-proven Gleason 6 prostate cancer: a retrospective cohort study. BMC Urol Guo CH, Zhu LY, Chi SP, Tan X, Luan Y, Ding XF. PMID: 42958541 [PubMed - indexed for MEDLINE]
	Impact of MRI-to-surgery interval on pathological upstaging after robot-assisted radical prostatectomy: a real-world cohort study. BMC Urol Farag K, Mohamed T, Elhashamy H, Ramez M, Manivannan S, Kailavasan M, Alevizopoulos A. PMID: 42958519 [PubMed - indexed for MEDLINE]
	Association between lateral lobe enucleation time and urethral stricture after Holmium Laser Enucleation of the Prostate (HoLEP): a retrospective cohort study. BMC Urol Kayal, Aydo. PMID: 42958233 [PubMed - indexed for MEDLINE]
	Integration of bulk RNA-seq data with single-cell RNA-seq data to identify urinary biomarkers derived from prostate tumor tissues. BMC Urol Shen Y, Guo Y, Wu Y, Dai L, Liu J, Zhu T, Xu J, Li H, Yang R, Cai Z, Fei X. PMID: 42958227 [PubMed - indexed for MEDLINE]
	Predicting malignant histology in small renal masses: the role of anatomical and radiological nephrometry scores. BMC Urol Çetinkaya MB, Kartal , Alk, Atlano, , Ço, Sevim M, Aras B. PMID: 42958163 [PubMed - indexed for MEDLINE]
	Overexpression of small nucleolar RNA host gene family members predicts poor bladder cancer prognosis: based on a systematic review and meta-analysis. BMC Cancer Hao WP, Lin ZB, Ke L, Liu HJ, Su CQ, Fu LM, Hong SB. PMID: 42958110 [PubMed - indexed for MEDLINE]
	Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial. Prostate Cancer Prostatic Dis Guer M, Lazarovich A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, Brito J, Shore ND, Struck JP, Schostak M, Harland N, Rodriguez-Socarrás M, Brisbane WG, Lughezzani G, Toledano H, Ouertani MS, Macek P, Fung C, Tu W, Gusenleitner A, Günzel K, Incze PF, George AK, Pereira JG, Jansen R, Renzulli J 2nd, Klotz L, Kinnaird A. PMID: 42957822 [PubMed - as supplied by publisher]
	Two-year longitudinal changes in pressure-flow study parameters and prostate morphology after prostatic urethral lift. World J Urol Kyoda Y, Shibamori K, Matsuki M, Shindo T, Hashimoto K, Tanaka T, Masumori N. PMID: 42957813 [PubMed - indexed for MEDLINE]
	Prostate-specific Membrane Antigen PET/Computed Tomography in Prostate Cancer: Staging, Restaging, Interpretation, and Clinical Management. Radiol Clin North Am Demirci RA, Iravani A. PMID: 42957399 [PubMed - indexed for MEDLINE]
	Does a digital support intervention reduce sedentary behaviour during cancer treatment in individuals with breast, prostate or colorectal cancer? Study protocol for a Swedish multicentre randomised controlled trial. BMJ Open Rådman L, Zetterlund J, von Heideken Wågert P, Henriksson A. PMID: 42957304 [PubMed - in process]
	Sequential intravesical mitomycin-C and gemcitabine therapy for BCG-unresponsive high-risk non-muscle-invasive bladder cancer: protocol for a prospective, open-label, single-arm, multicentre phase II (IMGeS) study. BMJ Open Lee HW, Park YH, Kim KH, Jung EH, Song G, Lee HH, Lee DE, Kang SH, Jeong BC, Ham WS, Jung SI, Oh JJ, Seo HK. PMID: 42957299 [PubMed - in process]
	Prostate-directed Radiotherapy in Selected Patients With Metastatic Castration-sensitive Prostate Cancer: A Real-world Case Series. In Vivo Furubayashi N, Nakashima T, Uehara R, Kojima T, Nakano Y, Kataoka A, Abe M, Negishi T. PMID: 42957244 [PubMed - indexed for MEDLINE]
	The Silent Half of the Couple: Partner Sexual and Psychosocial Outcomes in Penile Cancer. In Vivo Dell'atti L, Slyusar V. PMID: 42957238 [PubMed - indexed for MEDLINE]
	Usefulness of Texture Analysis in (11)C-Choline PET/CT for Patients With Prostate Cancer. In Vivo Tsuchitani T, Kitajima K, Takahashi Y, Yamamoto S, Yamakado K. PMID: 42957231 [PubMed - indexed for MEDLINE]
	Impact of PSMA PET/CT Staging on Long-Term Outcomes in Patients with Clinically Localized Prostate Cancer: Results of a Large Single-Center Cohort. J Nucl Med Esmaeilzadeh Asl S, Hoberück S, Sonnenfeld A, Stange T, Böhme H, Klimova A, Rentsch A, Hölscher T, Boehm K, Thomas C, Miederer M. PMID: 42957210 [PubMed - as supplied by publisher]
	Role of [(18)F]F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and Negative PSMA PET Results: A Single-Center Study. J Nucl Med Szidonya L, Obrzut S, Lim JY, Latour E, Choudhary G, Hung A, Mallak N. PMID: 42957209 [PubMed - as supplied by publisher]
	Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study. J Nucl Med Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung K, Calais J, Eggener SE, Brisbane W, Reiter RE, Raman S, Weiner AB. PMID: 42957199 [PubMed - as supplied by publisher]
	Oncocytoma in a 10-year post-transplant allograft kidney: A rare case report. J Cancer Res Ther Kamboj M, Gupta G, Mehta A, Gupta B, Yadav G. PMID: 42955989 [PubMed - indexed for MEDLINE]
	Hydrogel simulation-based training for HoLEP: technical performance, cognitive workload, and self-efficacy across residency training levels in AEEP. World J Urol Padovani PZ, Thoman M, Bader A, Coffelt J, Palasi S, Souders CP, Duchene DA, Neff D, Palma-Zamora I, Molina WR, Whiles BB. PMID: 42955395 [PubMed - indexed for MEDLINE]
	Implementation of the HUGOâ„¢ RAS system for robot-assisted radical prostatectomy: a single-center comparison with the da Vinci Xi(Â®) system. World J Urol Moderegger A, Vonthein R, Fender HE, Reese AS, Praus F, Roesch MC, Merseburger AS, Osmonov D. PMID: 42955349 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 192499

Page 1 of 9625



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy